跳至主要内容
临床试验/CTRI/2024/01/062000
CTRI/2024/01/062000尚未招募不适用

comparison of meropenem based triple therapy versus minocycline based triple therapy for treatment of carbapenem resistant acinetobacter baumanii(CRAB) ventilator associated pneumonia - A prospective observational study

Not applicable1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年2月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
Patient treated with minocycline based triple thrapy will have better clinical cure rate and faster microbiological clearance as compared to meropenem based triple therapy

研究概览

简要总结

It is a prospective observatiobal study to study the clinical response , mortality rate at 7and 28 days , length of hospital stay and icu stay , time taken for microbiological eradication in patients having Carbapenem resistant acinetobacter baumanni (CRAB) in tracheal aspirate of  Ventilator associated pneumonia patient treated with minocycline versus meropenem based triple therapy. Clinical response will be assessed in terms of temperature resolution ,vasopressor requirement ,nature of bronchial secretion and PaO2/FiO2 ratio. Patient/relatives who refuse to give informed consent, patient of age <18years ,pregnant females ,moribund and brain dead patients and patient having known allergy to given drug regime will be excluded.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • Patients aged >18 years Patients having CRAB in tracheal aspirate of Ventilator associated pneumonia (VAP) patients according to culture report.

排除标准

  • The patient/relatives who refuse to give informed consent Age less than 18 years Pregnant females Moribund and Brain dead patients Patients with known allergy to given drug regime.

结局指标

主要结局

Patient treated with minocycline based triple thrapy will have better clinical cure rate and faster microbiological clearance as compared to meropenem based triple therapy

时间窗: 72 HOURS

次要结局

  • Mortality rate at 7 & 28 day , length of hospital stay & icu stay will be decreased.(72 HOURS)

研究者

发起方
Not applicable
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Prajapati Jinalben Kishorbhai

AIIMS JODHPUR

研究点 (1)

Loading locations...

相似试验